Contrast and virtual colonoscopy developer E-Z-EM said that it has been sued by Tyco Healthcare Group in a U.S. district court in Texas.
Tyco is alleging E-Z-EM's Empower CT and Empower CTA injector systems infringe a Tyco U.S. patent concerning medical fluid injectors, according to E-Z-EM of Lake Success, NY. E-Z-EM president and CEO Anthony Lombardo said that the company intends to vigorously defend the suit.
By AuntMinnie.com staff writers
July 2, 2007
Related Reading
E-Z-EM CFO resigns, May 1, 2007
E-Z-EM gets FDA nod for EmpowerMR, April 17, 2007
E-Z-EM grows sales in Q3, April 11, 2007
E-Z-EM shows positive Q2, January 10, 2007
E-Z-EM debuts EmpowerMR at RSNA, November 29, 2006
Copyright © 2007 AuntMinnie.com

















![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)


